Rosanoff Andrea, Dai Qi, Shapses Sue A
Center for Magnesium Education and Research, Pahoa, HI;
Vanderbilt Epidemiology Center, Department of Medicine, School of Medicine, Vanderbilt University, Nashville, TN; and.
Adv Nutr. 2016 Jan 15;7(1):25-43. doi: 10.3945/an.115.008631. Print 2016 Jan.
Although much is known about magnesium, its interactions with calcium and vitamin D are less well studied. Magnesium intake is low in populations who consume modern processed-food diets. Low magnesium intake is associated with chronic diseases of global concern [e.g., cardiovascular disease (CVD), type 2 diabetes, metabolic syndrome, and skeletal disorders], as is low vitamin D status. No simple, reliable biomarker for whole-body magnesium status is currently available, which makes clinical assessment and interpretation of human magnesium research difficult. Between 1977 and 2012, US calcium intakes increased at a rate 2-2.5 times that of magnesium intakes, resulting in a dietary calcium to magnesium intake ratio of >3.0. Calcium to magnesium ratios <1.7 and >2.8 can be detrimental, and optimal ratios may be ∼2.0. Background calcium to magnesium ratios can affect studies of either mineral alone. For example, US studies (background Ca:Mg >3.0) showed benefits of high dietary or supplemental magnesium for CVD, whereas similar Chinese studies (background Ca:Mg <1.7) showed increased risks of CVD. Oral vitamin D is widely recommended in US age-sex groups with low dietary magnesium. Magnesium is a cofactor for vitamin D biosynthesis, transport, and activation; and vitamin D and magnesium studies both showed associations with several of the same chronic diseases. Research on possible magnesium and vitamin D interactions in these human diseases is currently rare. Increasing calcium to magnesium intake ratios, coupled with calcium and vitamin D supplementation coincident with suboptimal magnesium intakes, may have unknown health implications. Interactions of low magnesium status with calcium and vitamin D, especially during supplementation, require further study.
尽管人们对镁已经有了很多了解,但对其与钙和维生素D的相互作用的研究却较少。食用现代加工食品饮食的人群镁摄入量较低。低镁摄入量与全球关注的慢性疾病(如心血管疾病、2型糖尿病、代谢综合征和骨骼疾病)有关,低维生素D水平也是如此。目前尚无简单、可靠的全身镁状态生物标志物,这使得人体镁研究的临床评估和解读变得困难。在1977年至2012年期间,美国钙摄入量的增长速度是镁摄入量的2至2.5倍,导致膳食钙与镁的摄入比>3.0。钙与镁的比例<1.7和>2.8可能有害,最佳比例可能约为2.0。背景钙与镁的比例会影响对任何一种矿物质的单独研究。例如,美国的研究(背景钙:镁>3.0)表明,高膳食或补充镁对心血管疾病有益,而类似的中国研究(背景钙:镁<1.7)则表明心血管疾病风险增加。在美国膳食镁含量低的年龄性别组中广泛推荐口服维生素D。镁是维生素D生物合成、运输和激活的辅助因子;维生素D和镁的研究都表明与几种相同的慢性疾病有关。目前关于这些人类疾病中镁与维生素D可能相互作用的研究很少。钙与镁摄入比的增加,再加上在镁摄入不足的情况下同时补充钙和维生素D,可能对健康有未知的影响。低镁状态与钙和维生素D的相互作用,尤其是在补充期间进行的相互作用,需要进一步研究。